Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/90649

Documents

In Collections

This item can be found in the following collections:

Heijde, D. van der; Deodhar, A.; Fleischmann, R.; Mease, P.J.; Rudwaleit, M.; Nurminen, T.; Davies, O. (2017)

Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis

Article / Letter to editor
All authors
Heijde, D. van der; Deodhar, A.; Fleischmann, R.; Mease, P.J.; Rudwaleit, M.; Nurminen, T.; Davies, O.
Date
2017-07-31
Journal
Arthritis Care and Research
Volume
69
Issue
7
Pages
1030 - 1039
DOI
doi:10.1002/acr.23092